Conducting exercise trials for obese adolescents within the effectiveness setting: A response with commentary to Ejima et al. (2019)

被引:2
|
作者
Chang, Yu-Kai [1 ,2 ]
Alderman, Brandon L. [3 ]
Chu, Chien-Heng [1 ]
Hung, Tsung-Min [1 ,2 ]
Liu, Jen-Hao [4 ]
机构
[1] Natl Taiwan Normal Univ, Dept Phys Educ, 162 Sect 1,Heping E Rd, Taipei 106, Taiwan
[2] Natl Taiwan Normal Univ, Inst Res Excellence Learning Sci, Taipei, Taiwan
[3] Rutgers State Univ, Ctr Alcohol Studies, Dept Kinesiolopy & Hlth, New Brunswick, NJ USA
[4] Natl Taiwan Sport Univ, Grad Inst Athlet & Coaching Sci, Taoyuan, Taiwan
关键词
Social support; Motivation; Adolescent obesity; Weight loss; Methodological considerations; GROWTH-HORMONE RESPONSES; PHYSICAL-ACTIVITIES; ENERGY-EXPENDITURE; WEIGHT-LOSS; OVERWEIGHT; INTENSITY; COMPENDIUM; RESISTANCE; ENDURANCE; MODERATE;
D O I
10.1016/j.psychsport.2019.101605
中图分类号
F [经济];
学科分类号
02 ;
摘要
We appreciate Ejima et al.'s interest in and comments towards our article describing a 12-week randomized controlled trial of a coordination exercise program on cognitive function in obese adolescents that was conducted at a junior high school in Taipei City, Taiwan (Liu et al., 2018). Ejima et al. mentioned the apparent extraordinary effects of the interv ention on body mass index (BMI) both in the magnitude of the effects and distribution of the weight loss. On several points, we agree with Ejima et al. and in the spirit of transparency and reproducibility, we appreciate the opportunity to set the record straight about our study. We also genuinely appreciate Ejima et al.'s time and efforts in reviewing our study and analyzing the data, and helping to uncover these mistakes. We hope this commentary aids in better understanding the findings from Liu et al. (2018) and in encouraging future effectiveness trials aimed at improving cognitive function, fitness, and BMI among obese adolescents.
引用
收藏
页数:6
相关论文
共 47 条
  • [1] Understanding the neural response to social rejection in adolescents with autism spectrum disorders: A commentary on Masten et al., McPartland et al. and Bolling et al.
    Sebastian, Catherine L.
    Blakemore, Sarah-Jayne
    DEVELOPMENTAL COGNITIVE NEUROSCIENCE, 2011, 1 (03) : 256 - 259
  • [3] RESPONSE TO GREENE ET AL.: INDUSTRY FUNDING AND PLACEBO QUIT RATE IN CLINICAL TRIALS OF NICOTINE REPLACEMENT THERAPY: A COMMENTARY ON ETTER ET AL. (2007)
    Etter, Jean-Francois
    Stapleton, John
    ADDICTION, 2010, 105 (12) : 2219 - 2219
  • [4] Response to the Commentary on Maes et al. "A Genetic Epidemiological Mega Analysis of Smoking Initiation in Adolescents."
    Maes, Hermine H.
    Neale, Michael C.
    NICOTINE & TOBACCO RESEARCH, 2017, 19 (09) : 1118 - 1119
  • [5] Commentary on Hamilton et al. (2019): Why aren't cannabis use rates declining among US adolescents?
    Grucza, Richard A.
    Borodovsky, Jacob T.
    ADDICTION, 2019, 114 (10) : 1773 - 1774
  • [6] Commentary on Grandellis et al. 2019: suggesting endogenous DNA as further player in the plant immune response to DOTAP
    Heil, Martin
    PLANTA, 2019, 250 (01) : 391 - 393
  • [7] Commentary on Grandellis et al. 2019: suggesting endogenous DNA as further player in the plant immune response to DOTAP
    Martin Heil
    Planta, 2019, 250 : 391 - 393
  • [8] "Does attention bias modification induce structural brain changes? A commentary on Abend et al. (2019)" - Response
    Abend, Rany
    Rosenfelder, Ariel
    Shamai, Dana
    Pine, Daniel S.
    Tavor, Ido
    Assaf, Yaniv
    Bar-Haim, Yair
    BIOLOGICAL PSYCHOLOGY, 2020, 152
  • [9] Response to the letter to the editor: "Is metabolic syndrome related to exercise autonomic modulation in obese adults? (Lopes et al., 2018)"
    Carvalho, Livia P.
    Di Thommazo-Luporini, Luciana
    Mendes, Renata G.
    Cabiddu, Ramona
    Ricci, Paula A.
    Basso-Vanelli, Renata P.
    Oliveira-Junior, Manoel C.
    Vieira, Rodolfo P.
    Bonjorno-Junior, Jose C.
    Oliveira, Claudio R.
    Luporini, Rafael L.
    Borghi-Silva, Audrey
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2019, 216 : 88 - 90
  • [10] Commentary on the real-world effectiveness of vedolizumab in therapy-experienced ulcerative colitis: A response to Azzam et al.
    Alameel, Turki A.
    Alhashim, Howra W.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2025, 31 (02): : 100 - 101